{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:37:18Z","timestamp":1792654638220,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T00:00:00Z","timestamp":1535932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T00:00:00Z","timestamp":1535932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The identification of drug targets is highly challenging, particularly for diseases of the brain. To address this problem, we developed and experimentally validated a general computational framework for drug target discovery that combines gene regulatory information with causal reasoning (\u201cCausal Reasoning Analytical Framework for Target discovery\u201d\u2014CRAFT). Using a systems genetics approach and starting from gene expression data from the target tissue, CRAFT provides a predictive framework for identifying cell membrane receptors with a direction-specified influence over disease-related gene expression profiles. As proof of concept, we applied CRAFT to epilepsy and predicted the tyrosine kinase receptor Csf1R as a potential therapeutic target. The predicted effect of Csf1R blockade in attenuating epilepsy seizures was validated in three pre-clinical models of epilepsy. These results highlight CRAFT as a systems-level framework for target discovery and suggest Csf1R blockade as a novel therapeutic strategy in epilepsy. CRAFT is applicable to disease settings other than epilepsy.<\/jats:p>","DOI":"10.1038\/s41467-018-06008-4","type":"journal-article","created":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T08:09:51Z","timestamp":1535443791000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["A systems-level framework for drug discovery identifies Csf1R as an anti-epileptic drug target"],"prefix":"10.1038","volume":"9","author":[{"given":"Prashant K.","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9949-0526","authenticated-orcid":false,"given":"Jonathan","family":"van Eyll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6257-9730","authenticated-orcid":false,"given":"Patrice","family":"Godard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Mazzuferi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4324-7372","authenticated-orcid":false,"given":"Andree","family":"Delahaye-Duriez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Van Steenwinckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Gressens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicte","family":"Danis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Vandenplas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrik","family":"Foerch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Leclercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Mairet-Coello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Cardenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Vanclef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liisi","family":"Laaniste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Niespodziany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Keaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Gasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaelle","family":"Gillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirill","family":"Shkura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon-Ah","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Behmoaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Kadiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2163-5921","authenticated-orcid":false,"given":"Enrico","family":"Petretto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1632-4101","authenticated-orcid":false,"given":"Rafal M.","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,3]]},"reference":[{"key":"6008_CR1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd3078","volume":"9","author":"SM Paul","year":"2010","unstructured":"Paul, S. M. et al. How to improve R&D productivity: the pharmaceutical industry\u2019s grand challenge. Nat. Rev. Drug Discov. 9, 203\u2013214 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"6008_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrd1470","volume":"3","author":"I Kola","year":"2004","unstructured":"Kola, I. & Landis, J. Can the pharmaceutical industry reduce attrition rates? Nat. Rev. Drug Discov. 3, 1\u20135 (2004).","journal-title":"Nat. Rev. Drug Discov."},{"key":"6008_CR3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nn.4205","volume":"19","author":"MR Johnson","year":"2016","unstructured":"Johnson, M. R. et al. Systems genetics identifies a convergent gene network for cognition and neurodevelopmental disease. Nat. Neurosci. 19, 223\u2013232 (2016).","journal-title":"Nat. Neurosci."},{"key":"6008_CR4","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nature08454","volume":"461","author":"EE Schadt","year":"2009","unstructured":"Schadt, E. E. Molecular networks as sensors and drivers of common human diseases. Nature 461, 218\u2013223 (2009).","journal-title":"Nature"},{"key":"6008_CR5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrg3575","volume":"15","author":"M Civelek","year":"2014","unstructured":"Civelek, M. & Lusis, A. J. Systems genetics approaches to understand complex traits. Nat. Rev. Genet. 15, 34\u201348 (2014).","journal-title":"Nat. Rev. Genet."},{"key":"6008_CR6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nrg3934","volume":"16","author":"NN Parikshak","year":"2015","unstructured":"Parikshak, N. N., Gandal, M. J. & Geschwind, D. H. Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders. Nat. Rev. Genet. 16, 441\u2013458 (2015).","journal-title":"Nat. Rev. Genet."},{"key":"6008_CR7","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrd2826","volume":"8","author":"EE Schadt","year":"2009","unstructured":"Schadt, E. E., Friend, S. H. & Shaywitz, D. A. A network view of disease and compound screening. Nat. Rev. Drug Discov. 8, 286\u2013295 (2009).","journal-title":"Nat. Rev. Drug Discov."},{"key":"6008_CR8","doi-asserted-by":"crossref","first-page":"14621","DOI":"10.1073\/pnas.1000138107","volume":"107","author":"F Iorio","year":"2010","unstructured":"Iorio, F. et al. Discovery of drug mode of action and drug repositioning from transcriptional responses. Proc. Natl. Acad. Sci. USA 107, 14621\u201314626 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"6008_CR9","doi-asserted-by":"publisher","first-page":"e0139446","DOI":"10.1371\/journal.pone.0139446","volume":"10","author":"Francesco Iorio","year":"2015","unstructured":"Iorio, F., Shrestha, R. L., Levin, N. & Boilot, V. A semi-supervised approach for refining transcriptional signatures of drug response and repositioning predictions. https:\/\/doi.org\/10.1371\/journal.pone.0139446, 1\u201321 (2015).","journal-title":"PLOS ONE"},{"key":"6008_CR10","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb, J. et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313, 1929\u20131935 (2006).","journal-title":"Science"},{"key":"6008_CR11","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.neuron.2016.01.034","volume":"89","author":"V Chandran","year":"2016","unstructured":"Chandran, V. et al. A systems-level analysis of the peripheral nerve intrinsic axonal growth program. Neuron 89, 956\u2013970 (2016).","journal-title":"Neuron"},{"key":"6008_CR12","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-016-1097-7","volume":"17","author":"A Delahaye-Duriez","year":"2016","unstructured":"Delahaye-Duriez, A. et al. Rare and common epilepsies converge on a shared gene regulatory network providing opportunities for novel antiepileptic drug discovery. Genome Biol. 17, 245 (2016).","journal-title":"Genome Biol."},{"key":"6008_CR13","doi-asserted-by":"publisher","unstructured":"Musa, A. et al. A review of connectivity map and computational approaches in pharmacogenomics. Brief. Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbw112 (2017).","DOI":"10.1093\/bib\/bbw112"},{"key":"6008_CR14","volume":"6","author":"MR Johnson","year":"2015","unstructured":"Johnson, M. R. et al. Systems genetics identifies Sestrin 3 as a regulator of a proconvulsant gene network in human epileptic hippocampus. Nat. Commun. 6, 6031 (2015).","journal-title":"Nat. Commun."},{"key":"6008_CR15","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/nature09386","volume":"467","author":"M Heinig","year":"2010","unstructured":"Heinig, M. et al. A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk. Nature 467, 460\u2013464 (2010).","journal-title":"Nature"},{"key":"6008_CR16","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.cell.2014.09.021","volume":"159","author":"JC Chen","year":"2014","unstructured":"Chen, J. C. et al. Identification of causal genetic drivers of human disease through systems-level analysis of regulatory networks. Cell 159, 402\u2013414 (2014).","journal-title":"Cell"},{"key":"6008_CR17","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nrd2199","volume":"5","author":"JP Overington","year":"2006","unstructured":"Overington, J. P., Al-Lazikani, B. & Hopkins, A. L. {H}ow many drug targets are there? Nat. Rev. Drug Discov. 5, 993\u2013996 (2006).","journal-title":"Nat. Rev. Drug Discov."},{"key":"6008_CR18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1535-7511.2008.00272.x","volume":"8","author":"M Rogawski","year":"2008","unstructured":"Rogawski, M. & Johnson, M. Intrinsic severity as a determinant of antiepileptic drug refractoriness. Epilepsy Curr. 8, 127\u2013130 (2008).","journal-title":"Epilepsy Curr."},{"key":"6008_CR19","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrd4126","volume":"12","author":"W Loscher","year":"2013","unstructured":"Loscher, W., Klitgaard, H., Twyman, R. E. & Schmidt, D. New avenues for anti-epileptic drug discovery and development. Nat. Rev. Drug Discov. 12, 757\u2013776 (2013).","journal-title":"Nat. Rev. Drug Discov."},{"key":"6008_CR20","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1093\/brain\/awh267","volume":"127","author":"A Gaitatzis","year":"2004","unstructured":"Gaitatzis, A., Johnson, A. L., Chadwick, D. W., Shorvon, S. D. & Sander, J. W. Life expectancy in people with newly diagnosed epilepsy. Brain 127, 2427\u20132432 (2004).","journal-title":"Brain"},{"issue":"10","key":"6008_CR21","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1093\/brain\/awu206","volume":"137","author":"Doug Speed","year":"2014","unstructured":"Speed, D. et al. Describing the genetic architecture of epilepsy through heritability analysis. Brain https:\/\/doi.org\/10.1093\/brain\/awu206 (2014).","journal-title":"Brain"},{"key":"6008_CR22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.expneurol.2012.08.022","volume":"238","author":"M Mazzuferi","year":"2012","unstructured":"Mazzuferi, M., Kumar, G., Rospo, C. & Kaminski, R. M. Rapid epileptogenesis in the mouse pilocarpine model: Video-EEG, pharmacokinetic and histopathological characterization. Exp. Neurol. 238, 156\u2013167 (2012).","journal-title":"Exp. Neurol."},{"key":"6008_CR23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.expneurol.2007.06.021","volume":"207","author":"I Groticke","year":"2007","unstructured":"Groticke, I., Hoffmann, K. & Loscher, W. Behavioral alterations in the pilocarpine model of temporal lobe epilepsy in mice. Exp. Neurol. 207, 329\u2013349 (2007).","journal-title":"Exp. Neurol."},{"key":"6008_CR24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fgene.2011.00088","volume":"2","author":"H Clifford","year":"2011","unstructured":"Clifford, H., Wessely, F., Pendurthi, S. & Emes, R. D. Comparison of clustering methods for investigation of genome-wide methylation array data. Front. Genet. 2, 88 (2011).","journal-title":"Front. Genet."},{"key":"6008_CR25","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/1467-9868.00293","volume":"63","author":"R Tibshirani","year":"2001","unstructured":"Tibshirani, R., Walther, G. & Hastie, T. Estimating the number of clusters in a data set via the gap statistic. J. R. Stat. Soc. Ser. B 63, 411\u2013423 (2001).","journal-title":"J. R. Stat. Soc. Ser. B"},{"key":"6008_CR26","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1126\/science.aaa1934","volume":"347","author":"A Zeisel","year":"2015","unstructured":"Zeisel, A. et al. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq. Science 347, 1138\u20131142 (2015).","journal-title":"Science"},{"key":"6008_CR27","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1093\/bioinformatics\/btp502","volume":"25","author":"Y Choi","year":"2009","unstructured":"Choi, Y. & Kendziorski, C. Statistical methods for gene set co-expression analysis. Bioinformatics 25, 2780\u20132786 (2009).","journal-title":"Bioinformatics"},{"key":"6008_CR28","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1046\/j.1528-1157.2002.26401.x","volume":"43","author":"SR Haut","year":"2002","unstructured":"Haut, S. R., Swick, C., Freeman, K. & Spencer, S. Seizure clustering during epilepsy monitoring. Epilepsia 43, 711\u2013715 (2002).","journal-title":"Epilepsia"},{"key":"6008_CR29","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/ng.134","volume":"40","author":"E Petretto","year":"2008","unstructured":"Petretto, E. et al. Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass. Nat. Genet. 40, 546\u2013552 (2008).","journal-title":"Nat. Genet."},{"key":"6008_CR30","doi-asserted-by":"publisher","unstructured":"Parikshak, N. N. et al. Genome-wide changes in lncRNA, alternative splicing, and cortical patterning in autism. Nature https:\/\/doi.org\/10.1101\/077057 (2016).","DOI":"10.1101\/077057"},{"key":"6008_CR31","doi-asserted-by":"crossref","first-page":"9950","DOI":"10.1073\/pnas.1305814110","volume":"110","author":"JZ Li","year":"2013","unstructured":"Li, J. Z. et al. Circadian patterns of gene expression in the human brain and disruption in major depressive disorder. Proc. Natl. Acad. Sci. USA 110, 9950\u20139955 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"6008_CR32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2796.2011.02431.x","volume":"270","author":"M Maroso","year":"2011","unstructured":"Maroso, M. et al. Interleukin-1 type 1 receptor\/Toll-like receptor signalling in epilepsy: the importance of IL-1beta and high-mobility group box 1. J. Intern. Med. 270, 319\u2013326 (2011).","journal-title":"J. Intern. Med."},{"key":"6008_CR33","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.neuron.2014.02.040","volume":"82","author":"MRP Elmore","year":"2014","unstructured":"Elmore, M. R. P. et al. Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron 82, 380\u2013397 (2014).","journal-title":"Neuron"},{"key":"6008_CR34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1158\/2159-8274.CD-10-0028","volume":"1","author":"DG DeNardo","year":"2011","unstructured":"DeNardo, D. G. et al. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov. 1, 54\u201367 (2011).","journal-title":"Cancer Discov."},{"key":"6008_CR35","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/glia.23038","volume":"64","author":"H Koso","year":"2016","unstructured":"Koso, H. et al. Conditional rod photoreceptor ablation reveals Sall1 as a microglial marker and regulator of microglial morphology in the retina. Glia 64, 2005\u20132024 (2016).","journal-title":"Glia"},{"key":"6008_CR36","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/cns.12523","volume":"22","author":"V Duveau","year":"2016","unstructured":"Duveau, V. et al. Differential effects of antiepileptic drugs on focal seizures in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy. CNS Neurosci. Ther. 22, 497\u2013506 (2016).","journal-title":"CNS Neurosci. Ther."},{"key":"6008_CR37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neuropharm.2014.11.008","volume":"90","author":"S Klein","year":"2015","unstructured":"Klein, S., Bankstahl, M. & L\u00f6scher, W. Inter-individual variation in the effect of antiepileptic drugs in the intrahippocampal kainate model of mesial temporal lobe epilepsy in mice. Neuropharmacology 90, 53\u201362 (2015).","journal-title":"Neuropharmacology"},{"key":"6008_CR38","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/WNP.0b013e3181fe0709","volume":"27","author":"J Dyhrfjeld-Johnsen","year":"2010","unstructured":"Dyhrfjeld-Johnsen, J., Berdichevsky, Y., Swiercz, W., Sabolek, H. & Staley, K. J. Interictal spikes precede ictal discharges in an organotypic hippocampal slice culture model of epileptogenesis. J. Clin. Neurophysiol. 27, 418\u2013424 (2010).","journal-title":"J. Clin. Neurophysiol."},{"key":"6008_CR39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5698\/1535-7511-11.5.153","volume":"11","author":"M Wong","year":"2011","unstructured":"Wong, M. Epilepsy in a dish: an in vitro model of epileptogenesis. Epilepsy Curr. 11, 153\u2013154 (2011).","journal-title":"Epilepsy Curr."},{"key":"6008_CR40","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1528-1167.2009.02339.x","volume":"51","author":"A White","year":"2010","unstructured":"White, A. et al. EEG spike activity precedes epilepsy after kainate-induced status epilepticus. Epilepsia 51, 371\u2013383 (2010).","journal-title":"Epilepsia"},{"key":"6008_CR41","doi-asserted-by":"crossref","first-page":"3632 LP","DOI":"10.1182\/blood.V118.21.3632.3632","volume":"118","author":"E Burton","year":"2011","unstructured":"Burton, E. et al. The novel inhibitor PLX3397 effectively inhibits FLT3-mutant AML. Blood 118, 3632 LP\u20133633632 (2011).","journal-title":"Blood"},{"key":"6008_CR42","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.seizure.2011.01.003","volume":"20","author":"W L\u00f6scher","year":"2011","unstructured":"L\u00f6scher, W. Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs. Seizure 20, 359\u2013368 (2011).","journal-title":"Seizure"},{"key":"6008_CR43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2012.04.004","volume":"69","author":"A Vezzani","year":"2013","unstructured":"Vezzani, A., Friedman, A. & Dingledine, R. J. The role of inflammation in epileptogenesis. Neuropharmacology 69, 16\u201324 (2013).","journal-title":"Neuropharmacology"},{"key":"6008_CR44","doi-asserted-by":"crossref","first-page":"e0122912","DOI":"10.1371\/journal.pone.0122912","volume":"10","author":"MRP Elmore","year":"2015","unstructured":"Elmore, M. R. P., Lee, R. J., West, B. L. & Green, K. N. Characterizing newly repopulated microglia in the adult mouse: impacts on animal behavior, cell morphology, and neuroinflammation. PLoS ONE 10, e0122912 (2015).","journal-title":"PLoS ONE"},{"key":"6008_CR45","doi-asserted-by":"crossref","first-page":"D481","DOI":"10.1093\/nar\/gkv1351","volume":"44","author":"A Fabregat","year":"2016","unstructured":"Fabregat, A. et al. The reactome pathway knowledgebase. Nucleic Acids Res. 44, D481\u2013D487 (2016).","journal-title":"Nucleic Acids Res."},{"key":"6008_CR46","doi-asserted-by":"crossref","first-page":"D685","DOI":"10.1093\/nar\/gkq1039","volume":"39","author":"EG Cerami","year":"2011","unstructured":"Cerami, E. G. et al. Pathway Commons, a web resource for biological pathway data. Nucleic Acids Res. 39, D685\u2013D690 (2011).","journal-title":"Nucleic Acids Res."},{"key":"6008_CR47","volume":"5","author":"H Han","year":"2015","unstructured":"Han, H. et al. TRRUST: a reference database of human transcriptional regulatory interactions. Sci. Rep. 5, 11432 (2015).","journal-title":"Sci. Rep."},{"key":"6008_CR48","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1517\/14740338.2015.1010508","volume":"14","author":"A Vezzani","year":"2015","unstructured":"Vezzani, A. Anti-inflammatory drugs in epilepsy: does it impact epileptogenesis? Expert Opin. Drug Saf. 14, 583\u2013592 (2015).","journal-title":"Expert Opin. Drug Saf."},{"key":"6008_CR49","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/ana.23940","volume":"74","author":"M Mazzuferi","year":"2013","unstructured":"Mazzuferi, M. et al. Nrf2 defense pathway: experimental evidence for its protective role in epilepsy. Ann. Neurol. 74, 560\u2013568 (2013).","journal-title":"Ann. Neurol."},{"key":"6008_CR50","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","volume":"32","author":"RJ Racine","year":"1972","unstructured":"Racine, R. J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32, 281\u2013294 (1972).","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"6008_CR51","volume":"14","author":"D Kim","year":"2013","unstructured":"Kim, D. et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013).","journal-title":"Genome Biol."},{"key":"6008_CR52","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics (Oxford, England) 26, 139\u2013140 (2010).","journal-title":"Bioinformatics (Oxford, England)"},{"key":"6008_CR53","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. Ser. B"},{"key":"6008_CR54","doi-asserted-by":"crossref","unstructured":"Peterson, L. E. Analysis of microarray-based transcriptional profiles. Genome Biol. 3, software0002.1\u2013software0002.8 (2002).","DOI":"10.1186\/gb-2002-3-7-software0002"},{"key":"6008_CR55","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/bioinformatics\/btp603","volume":"26","author":"BPP Van houte","year":"2009","unstructured":"Van houte, B. P. P. & Heringa, J. Accurate confidence aware clustering of array CGH tumor profiles. Bioinformatics 26, 6\u201314 (2009).","journal-title":"Bioinformatics"},{"key":"6008_CR56","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/ijc.27941","volume":"132","author":"B Otto","year":"2013","unstructured":"Otto, B. et al. Transcription factors link mouse WAP-T mammary tumors with human breast cancer. Int. J. Cancer 132, 1311\u20131322 (2013).","journal-title":"Int. J. Cancer"},{"key":"6008_CR57","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/01621459.1963.10500845","volume":"58","author":"JH Ward","year":"1963","unstructured":"Ward, J. H. Hierarchical grouping to optimize an objective function. J. Am. Stat. Assoc. 58, 236\u2013244 (1963).","journal-title":"J. Am. Stat. Assoc."},{"key":"6008_CR58","first-page":"1","volume":"3","author":"T Cali\u0144ski","year":"2007","unstructured":"Cali\u0144ski, T. & Harabasz, J. A dendrite method for cluster analysis. Commun. Stat. 3, 1\u201327 (2007).","journal-title":"Commun. Stat."},{"key":"6008_CR59","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2007-8-2-r19","volume":"8","author":"J Hellemans","year":"2007","unstructured":"Hellemans, J., Mortier, G., De Paepe, A., Speleman, F. & Vandesompele, J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol. 8, R19 (2007).","journal-title":"Genome Biol."},{"key":"6008_CR60","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-7-research0034","volume":"3","author":"J Vandesompele","year":"2002","unstructured":"Vandesompele, J. et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3, RESEARCH0034 (2002).","journal-title":"Genome Biol."},{"key":"6008_CR61","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/bioinformatics\/btn224","volume":"24","author":"P Du","year":"2008","unstructured":"Du, P., Kibbe, W. A. & Lin, S. M. lumi: a pipeline for processing Illumina microarray. Bioinformatics (Oxford, England) 24, 1547\u20131548 (2008).","journal-title":"Bioinformatics (Oxford, England)"},{"key":"6008_CR62","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nmeth.3252","volume":"12","author":"W Huber","year":"2015","unstructured":"Huber, W. et al. Orchestrating high-throughput genomic analysis with Bioconductor. Nat. Methods 12, 115\u2013121 (2015).","journal-title":"Nat. Methods"},{"key":"6008_CR63","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"6008_CR64","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s13311-018-0607-6","volume":"15","author":"SA Chong","year":"2018","unstructured":"Chong, S.-A. et al. Intrinsic inflammation is a potential anti-epileptogenic target in the Organotypic Hippocampal Slice Model. Neurotherapeutics 15, 470\u2013488 (2018).","journal-title":"Neurotherapeutics"},{"key":"6008_CR65","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0022-1759(88)90310-9","volume":"115","author":"T Decker","year":"1988","unstructured":"Decker, T. & Lohmann-Matthes, M. A quick and simple method for the quantitation of LDH release in measurements of cellular cytotoxicity and TNF activity. J. Immunol. Methods 115, 61\u201369 (1988).","journal-title":"J. Immunol. Methods"},{"key":"6008_CR66","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1111\/j.1528-1167.2009.02089.x","volume":"50","author":"RM Kaminski","year":"2009","unstructured":"Kaminski, R. M. et al. Proepileptic phenotype of SV2A-deficient mice is associated with reduced anticonvulsant efficacy of levetiracetam. Epilepsia 50, 1729\u20131740 (2009).","journal-title":"Epilepsia"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06008-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06008-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06008-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T13:49:34Z","timestamp":1720532974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06008-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,3]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["6008"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-06008-4","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733932397.793556114","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.733932397.793581715","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,3]]},"assertion":[{"value":"30 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.v.E., P.G., M.M., J.V.S., B.D., C.V., P.F., K.L., G.M.-C., A.C., F.V., I.N., J.K., J.G., G.G., S.-A.C., I.K., and R.M.K. are employees of UCB Pharma. M.R.J. and E.P. have received research funding from UCB Pharma. The authors declare no other competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3561"}}